Lactobacilli and bifidobacteria are important members of the gastrointestinal microflora of man and animals. There is a substantial and growing body of evidence that these microbes provide benefits to the host in which they reside. Understanding the roles of these two groups of bacteria in the intestine continues to be a significant challenge. To this end, genetic characterisation and manipulation of intestinal lactobacilli and bifidobacteria is essential to define their contributions to the intestinal microflora, and to potentially exploit any beneficial or unique properties. This review will describe the tools and strategies currently available for the genetic manipulation of lactobacilli and bifidobacteria. Additionally, the ramifications and opportunities that may arise as a result of the genetic manipulation of probiotic lactobacilli and bifidobacteria will be addressed.
Introduction
The gastrointestinal tract of vertebrate animals is the most densely colonized region of the human body (112, 127) . There are approximately 10 12 bacteria per gram of contents in the large intestine, which is estimated to contain several hundred bacterial species (99) . The accumulated evidence indicates that this collection of microbes has a powerful influence on the host in which it resides. Comparisons between germfree and conventional animals have shown that many biochemical, physiological and immunological functions are influenced by the presence of the diverse and metabolically active bacterial community residing in the gastrointestinal tract (80, 111, 112) .
The use of live microbes as dietary adjuncts or probiotics has received considerable commercial and scientific attention (127) . Fuller (34) defined a probiotic as a "live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance." This definition was broadened by Havenaar and Huis in't Veld (41) to a "mono-or mixed-culture of live microorganisms" which benefits man or animals by improving the properties of the indigenous microflora. A number of excellent overviews are available on probiotics (8, 27, 36, 37, 60, 81, 94, 95) . The potential health benefits attributed to probiotics include the following:
• maintenance of the normal microflora • pathogen interference, exclusion, and antagonism • immunostimulation and immunomodulation • anticarcinogenic and antimutagenic activities • alleviation of symptoms of lactose intolerance • reduction in serum cholesterol Many of the effects attributed to the ingestion of probiotics, however, remain convoluted and scientifically unsubstantiated (81) , and it is rare that specific health claims can be made (96) . This situation could be resolved by providing exact descriptions of the probiotic microorganisms involved and developing an understanding of the control mechanisms for those functional properties that are vital to the survival and activity of these organisms in the human gastrointestinal tract. However, the perceived desirable qualities of probiotics are many (Table 1) , and it is highly unlikely that any one strain will harbor all the qualities or provide the multitude of proposed benefits. There is a myriad of possible probiotic strains, coupled with a highly diverse set of phenotypes and potential benefits. Therefore, screening genetic traits offers considerable promise in attacking the almost insurmountable task of surveying for functional probiotic properties, or building combinations of probiotic strains that can elicit multiple effects. Moreover, genetic modification of probiotic bacteria offers the added developmental potential to annex new beneficial activities (e.g. vaccine presentation) or improve the effectiveness of existing properties (e.g. bacteriocin levels).
Lactobacilli and bifidobacteria constitute two extremely important groups of probiotic bacteria. As members of the normal microflora of the gastrointestinal tract of humans, they offer considerable potential as probiotics because of their history of safe use and the general body of evidence that supports their positive roles. Genetic analysis and manipulation of these bacteria will be paramount to understanding their probiotic roles and maximising their performance in vitro and in vivo. The field is now poised to exploit genetic approaches in the investigation of these bacteria and their probiotic capabilities. However, recent surges in the development of genetic tools for lactic acid bacteria have lagged significantly for bifidobacteria and intestinal lactobacilli. Genetic work on bifidobacteria is in its infancy. For the lactobacilli, there have been a number of significant developments (reviewed in 53, 86) . However, these efforts have been dispersed over a collection of newly recognized, and collectively significant probiotic lactobacilli (e.g. Lactobacillus acidophilus, Lactobacillus gasseri, Lactobacillus johnsonii, Lactobacillus reuteri, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus paracasei) resulting in only incremental steps in our understanding of the genetic programming and potential of the Lactobacillus species, overall. The following is intended to overview the tools available for genetic manipulation of lactobacilli and bifidobacteria and discuss opportunities for genetic analysis and modification of these two key groups of probiotic bacteria.
Lactobacilli
Members of the genus Lactobacillus constitute an extremely diverse and important group of organisms, of pIL253 (high copy) (109) and an E. coli P15A origin (82) . pTRKL/H series vectors replicate via a theta mechanism which is broadly functional across lactobacilli and provides more structural stability to recombinant plasmids since a ssDNA intermediate is not involved. These vectors work well in L. johnsonii and L. gasseri, but not in L. acidophilus. The third vector design incorporates selectable markers and alternative replication origins for gram-negative bacteria to small cryptic Lactobacillus plasmids, a number of which have been completely sequenced (13, 15, 65, 73, 86, 98) . Plasmid vectors based on RCR Lactobacillus replicons marked with Em r and/or Cm r , lacZ or xyl (xylose catabolism) have been compiled by Pouwels and Leer (86) and continue to appear (50, 54, 120) . In some cases, the host range of Lactobacillus-based vectors includes lactobacilli and other gram-positive bacteria, but not E. coli (85, 86) . However, several replicons of plasmids isolated from Lactobacillus have now been found that have a broader host range, allowing replication in E. coli, Bacillus, and various lactic acid-producing bacteria (LAB) and include: pPSC20/pPSC22 (20) , pLC2 (54), pGT633 (115), pA1 (120) and pLA106 (98) . Vectors of this type may be useful for genetic modification and analysis of intestinal lactobacilli, in which other RCR or theta replicons are unstable. In contrast, plasmids with limited host range replicons have been identified in L. reuteri (1) and L. crispatus (86) . As noted by Pouwels and Leer (86) , these vectors may be particularly useful in the development of food/vaccine-grade vectors as their small host range makes them much less likely to promote horizontal gene transfer to other bacterial species.
Electrotransformation
Electroporation has been used widely for gene transfer and cloning in many lactobacilli (6, 10, 17, 65, 85) . Transformation of intestinal lactobacilli at reasonable frequencies has been reported widely for L. gasseri, L. johnsonii, and L. reuteri (1, 31, 50, 64, 65, 66, 77, 115) , and these species appear highly amenable for DNA manipulation and gene transfer. However, electroporation protocols that are effective for many lactobacilli have not yielded transformants of type A1, L. acidophilus strains. Early reports of electroporation of "L. acidophilus" from our laboratory (64, 65) actually involved strains of L. gasseri and L. johnsonii strains which were reclassified on the basis (122) . L. acidophilus ATCC 4356 (A1-neotype) and ATCC 700396 (NCFM/N2) were transformed with pGK12 and pGhost (67) at frequencies ranging from 10 -10 2 transformants/µg DNA. While these frequencies are low when compared to other species transformable at 10 5 -10 7 /µg, they provide opportunities for genetic modification and experimentation with these two important L. acidophilus strains, one the neotype and the second, a commercial strain distributed widely in acidophilus milk and a variety of dietary-health products.
Conjugation
While broad host range vectors like pAMß1 and pVA797 are transmissible from heterologous donors (Lactococcus and Enterococcus) to lactobacilli, reports of native conjugation systems in lactobacilli are few. L. gasseri transconjugants did not act as donors for second round transfers (64) whereas L. reuteri transconjugants could transfer pAMß1 to L. reuteri and E. faecalis (114) . Conjugal transfer of plasmid-associated lactose fermenting ability in L. casei was reported by Chassy and Rokaw (19) . Since this initial report, however, the only evidence which has appeared for a native conjugal system in Lactobacillus species is in L. johnsonii (76) . Bacteriocin (lactacin F) production and immunity in L. johnsonii VPI11088 (NCK88) is chromosomally encoded on a conjugative episomal element (30, 77) . This conjugation system was employed to mobilize pSA3 in conjugation experiments from L. johnsonii (pSA3) donors leading to the recovery of a pSA3 resolution product carrying IS1223 (121) . This IS-element is functional in L. gasseri, L. johnsonii, and L. acidophilus. While it is clear that conjugation is a mechanism for gene transfer in lactobacilli, the extent and usefulness of conjugative systems have not been examined to a significant degree. Because many of the type A1 strains of the L. acidophilus group are recalcitrant to electroporation, conjugation may be a more useful and potentially broader range tool for gene transfer in lactobacilli.
Integration and Insertion Systems
Integration of genes/vectors into the bacterial chromosome is a critical genetic tool for insertional mutagenesis, creation of physical/genetic maps, and directed manipulations such as gene stabilization, fusion, amplification, deletion, and replacement. In the lactobacilli, a number of new technologies are emerging that utilize IS-elements, attP/ integrase systems, or homologous recombination strategies via suicide or temperature-sensitive replicons.
Several different IS elements have been found in lactobacilli (108, 110, 121, 126) . One of these IS elements, IS1223, has been used for construction of suicide integration vectors using pSA3 (121) and pGhost replicons (Aoyama, Walker and Klaenhammer, unpublished) . Integration experiments have demonstrated that IS1223 directs random insertions in L. acidophilus and L. gasseri chromosomes where there is no detectable homology for the IS element. In contrast, insertions in L. johnsonii, where resident copies of IS1223 are found, show a site preference. While their use as stable integration vectors would be limited due to their propensity for additional transposition events, the discovery of functional IS elements in lactobacilli should aid in the development of functional mutagenesis and insertional vectors for a variety of intestinal lactobacilli.
Establishment of the prophage state by temperate bacteriophages is a highly efficient and site-specific integration system. Insertion at a specific chromosomal location (attB) is mediated by a small region of homology on the phage (attP) and a phage-encoded integrase (int). The attP and intG of the L. gasseri temperate phage φadh have been cloned, sequenced, and used for construction of site-specific suicide integration vectors (31, 87) . While the vectors are functional across strains of L. gasseri, the attB sequence is not conserved in other intestinal lactobacilli (DeAntoni, Fremaux, Raya, and Klaenhammer, unpublished). The attP and intG of the L. delbrueckii subsp. bulgaricus temperate phage mv4 have also been used in the construction of a site-specific integration vector (7) . A particularly attractive aspect of this system is that the integration site for the vector is at the 3' end of a tRNA Ser gene and occurs without inactivation of this gene in lactobacilli. There are several advantages that phagebased integration systems offer for the genetic manipulation of lactobacilli for food or medical applications: insertions are stable and at single copy; large fragments encoding complex operons could be integrated; and, insertions occur at a specific, non-essential site that should not disrupt culture viability or activity.
Homologous recombination has been used extensively in the construction of integration vectors for accomplishing gene disruption, amplification, replacement, and insertions in a variety of bacteria. An important element for integration experiments is a reasonable frequency of electroporation since generation of integrants relies on both successful transformation and recombination events. As noted earlier, transformation via electroporation can be applied throughout the lactobacilli, but many species are transformable at frequencies that are only marginal for many integration experiments. To circumvent problems with low efficiencies, autoreplicating or temperature-sensitive plasmids, that replicate conditionally or are unstable in the absence of selection, should be employed. While the pGhost series of vectors contain temperature sensitive origins (67), these plasmids are problematic in lactobacilli because outgrowth of transformants at the permissive temperature (28°C) is very inefficient. Both pSA3 (3, 10, 88, Walker and Klaenhammer, unpublished) and pGK12-type plasmids (28, 44) exhibit features of conditional replication in lactobacilli and these plasmids have been exploited for various integration experiments via homologous recombination. In one report of homologous recombination in an intestinal Lactobacillus strain, disruption of the lafI gene occurred via a gene disruption cassette on pSA3, which was introduced into L. johnsonii (3). In this instance, conditional replication of pSA3 was directed by manipulation of the temperature and antibiotic concentration. Disruption of the cbh gene, which codes for conjugate bile salt hydrolase, was accomplished by delivering a chloramphenicol resistance gene-containing, disruption cassette on a ColE1 replicon in L. plantarum 44 Kullen and Klaenhammer (61) . Similarly, Fitzsimons et al., (28) integrated an active fragment of the α-amylase gene into the chromosome of L. plantarum at the cbh locus by utilizing an autoreplicative plasmid. Aside from these reports, the exploitation of homologous recombination for genetic manipulation for the intestinal lactobacilli has not occurred. Heterologous genes from a diverse group of microorganisms have been expressed in lactobacilli under the control of their own native heterologous promoter, a Lactobacillus promoter, or another promoter ( Table 2 ). The current list includes genes and expression signals from gram-negative and gram-positive bacteria, sporeformers, and fungi. While expression may occur, the level can vary dramatically based on the gene, promoter, and expression host. Heterologous gene expression will allow construction of novel lactobacilli with potentially valuable properties. However, additional efforts are needed to isolate strong, weak, and regulated promoters from intestinal lactobacilli where gene expression can be controlled under the conditions in the gastrointestinal tract. Heterologous gene expression in lactobacilli has developed a critical need to investigate and control excretion and secretion processes in order to export proteins, enzymes, and potentially antigenic epitopes. The S-layer genes of L. brevis (119) and L. acidophilus (12) have been cloned and sequenced. The regulatory and secretion signals of the L. brevis S-layer gene has been used in the design of highly efficient synthesis and export system for heterologous proteins and epitopes. Gene fusions to TEM-ß-lactamase showed that the S-layer gene promoters and secretion signals functioned well in Lactococcus (Lc.) lactis, L. plantarum, and L. brevis, while in L. casei and L. gasseri, the recognition of these signals was less efficient (100). Using the Bacillus licheniformis α-amylase gene as a reporter gene, Hols et al., (44) successfully cloned a number of L. plantarum expression and secretion signals capable of directing extracellular α-amylase. The regulatory and secretion signals for α-amylase from L. amylovorus are also functional in L. plantarum (28) . An expression system in L. plantarum and L. fermentum, based upon the regulatory signals of protein A of Staphylococcus aureus was used to direct the synthesis and export of a gene fusion product, containing a region of a chlamydial major outer-membrane protein gene (93) . Similarly, Hols et al., (45) designed an expression system containing the P25 promoter of S. thermophilus, ldhD RBS from L. pentosus, and the secretion signal of M6 protein of Streptococcus pyogenes This system was capable of the expression and secretion of a large quantity (approx. 10 mg/L culture medium) of the model antigen, M6-gp41E. Lastly, small N-terminal leader sequences with a Gly-Gly processing motif are believed to direct the excretion and activation of class IIbacteriocins (52, 117) . LAB can use bacteriocin ABC transporters to export heterologous peptide bacteriocins, using either homologous or heterologous N-terminal extensions (2, 4, 117) . Whether or not gene fusions with these leader sequences would direct the export of heterologous, non-bacteriocin peptides or proteins has yet to be established. It is apparent, however, that signal peptide recognition and processing systems are present in lactobacilli which recognize, cleave, and secrete heterologous prepeptides.
Gene Expression
Cloning and characterisation of Lactobacillus genes has been accompanied by physical and phenotypic analysis of their expression signals. Many Lactobacillus genes are expressed in E. coli indicating that their expression signals are similar enough to be recognized in other bacteria (86). Moreover, phenotypic selection or complementation in E. coli has proven to be a successful strategy for cloning a number of genes which have been characterized to date (124, 105). The DNA-dependent RNA polymerase from L. acidophilus transcribed some, but not all E. coli promoters, in vitro (79). L. acidophilus promoters were also transcribed, and sequence analysis identified a -10 region similar to the E. coli consensus promoter sequence.
Bifidobacteria
Bacteria in the genus Bifidobacterium were initially described by Tissier around the turn of the century. Since this time, the classification of this group has been a point of some contention and confusion. The initial classification of bifidobacteria as Bacillus plus the phenotypic and morphological attributes that they share with many lactobacilli led to the popular belief that they belonged to the genus Lactobacillus (9). Classification by molecular methodologies have provided evidence that this is indeed a distinct genus and is more closely related to the Actinomycetaceae family than to Lactobacillaceae (59, 102) . As a result of their time spent in a poorly defined taxonomic position, little is known about the genetics of bifidobacteria and application of recombinant DNA technology to these organisms has been slow to occur. At present, there are 26 species of the genus Bifidobacterium animalis in a variety of commercial dairy products distributed world-wide. Meile et al., (72) recently made a description and proposal of a new species, B. lactis, which was isolated from a commercial yogurt. Given this strain's immediate habitat (fermented milk), very close phylogenetic proximity to B. animalis and the high degree of identity between the 16S rRNA sequences (98.6% over more than 1.4 kb) of this strain with B. animalis, it is likely that B. lactis is represented in the B. animalis isolates analyzed by Sanders et al., (97) and Yaeshima et al., (125) . Because of its widespread occurrence in fermented dairy foods, B. animalis, under any name, is certainly of significance to probiotics research from an industrial perspective.
Bifidobacterial Plasmids and Vectors
Plasmids in members of the genus Bifidobacterium were initially reported by Sgorbati et al., (106) . Similar to the lactobacilli, plasmids are detected only in a few species. From bifidobacteria isolated from the human gastrointestinal tract, only B. longum (83, 106, 107, 70) and B. breve (14, 46) have been shown to harbor plasmids. These plasmids are all cryptic and most have not been characterised beyond restriction mapping. One cryptic plasmid, pMB1, has been sequenced and appears to encode essential replication proteins (91) . The two putative replication proteins, whose genes have been designated orf1 and orf2, encoded on pMB1 show similarity to proteins encoded by plasmids pXZ10142 of Corynebacterium glutamicum and pAL500 of Mycobacterium fortuitum. It is noteworthy that, like Bifidobacterium, the genera Corynebacterium and Mycobacterium are members of the family Actinomycetaceae.
Since these first observations of plasmids, several innovations in the plasmid biology of bifidobacteria have occurred. Vectors, capable of transforming a variety of bifidobacteria, are of the general utility type with distinct replication origins and markers selectable in bifidobacteria and Escherichia coli. E. coli-Bifidobacterium shuttle vectors derived from the small cryptic plasmid described above, pMB1 (90, 91, 74) , and from other less well defined plasmids (69) have now been constructed. The first of these, pRM2 (74) , contains spectinomycin (Sp r ) and ampicillin (Ap r ) resistance determinants for selection in B. longum and E. coli, respectively. pMR2 also harbors a useful multiple cloning site, the putative origin of pMB1 and a ColE1 replication origin for B. longum and E. coli, respectively. Recently, new varieties of pMB1-based vectors have been constructed with Sp r , Em r and Cm r determinants for selection in bifidobacteria and the Ap r determinant for E. coli (90) . A small (2.8 kb) pMB1-based vector, pTRE3, which contains no cryptic DNA, a MCS and Cm r was also introduced with this series of shuttle vectors. While pTRE3 does not replicate in E. coli, it demonstrates excellent segregational stability (>95% cells harbor plasmids after 100 generations without selection) in B. animalis (90) . In addition to the pMB1-based vectors, E. coli-Corynebacterium shuttle vectors have been shown to replicate in B. animalis (5), which is in agreement with phylogenetic positioning of these two genera. It has also been demonstrated (5) that plasmid pLP825 (85) , which harbors a replicon from L. plantarum, and the broad host range Lactococcus plasmid, pGK12 (55) , are incapable of transforming B. animalis, suggesting that the replication functions of these AT-rich plasmids are poorly recognized by bifidobacteria.
Initially, transformation efficiencies of a variety of species of bifidobacteria with these plasmids were poor and irreproducible (74) , owing primarily to the fact that the procedures were designed for other bacteria. However, recent developments in transformation protocols by modification of growth medium and electric field strength (89) , modification of the electroporation buffer, and preincubation of cells at 4°C prior to addition of DNA and electroporation (5) have dramatically increased transformation efficiency for all strains tested thus far, including those significant to probiotic research.
Genetically Modified Microbes
While there is considerable potential for genetic modification and improvement of probiotic bacteria, there are formidable barriers that will limit commercial use, public acceptance and environmental release of genetically modified organisms (GMOs), particularly those capable of colonising body cavities and mucosal surfaces. Foremost among these barriers will be public acceptance of probiotic GMOs. This is an important issue that will be faced in every instance when a probiotic GMO is considered for release. Drawing comparisons to the success of the plant biotechnology industry in the U.S.A, it could be expected that public acceptance of probiotic GMOs will improve concurrently with incremental exposure to microbial products of biotechnology that are advantageous and provide tangible benefits. Various studies have already shown that consumers in developed countries will accept products manufactured or containing GMOs, if they offer benefits to health and product quality that the consumer can clearly recognize (118) . In this regard, because probiotics by definition, offer health benefits, consumers may willingly accept and use genetically modified probiotics if there are substantial and tangible benefits provided over their traditional counterparts.
Industries that manufacture lactic cultures and probiotics may also view GMOs favourably if self-imposed guidelines that adhere strictly to regulatory positions are evoked. The industry should be expected to favourably consider manufacturing GMOs if they offer a clear competitive advantage over their traditional counterparts. These advantages may reflect processing and economic gains, but the stakes can become significantly higher if health-based benefits can be associated with the probiotic GMO, or the product used to deliver it. Again, any linkage to health and well being has the potential to favour industrial positions on probiotic GMOs if clear and tangible benefits can be realized. At this point in time, any recombinant DNA technology used to create probiotic GMOs would require strict adherence to the concepts of self cloning (using DNA originating only from the same strain/species; sequence analysis of any modifications -e.g. deletions, additionsto ensure that new reading frames are not generated and that antibiotic resistance markers are not present in GMO). Ultimately, any GMO would require regulatory review and safety approval. In the U.S.A., regulatory scrutiny is focused on the safety of the GMO, not the process by which it was constructed. Indeed, biotechnology occurs via precise genetic modifications where the specific genetic changes are defined and the safety of the GMO can be quickly and rationally assessed. This approach is generally applauded by scientists over "black box" mutation and selection strategies, where the genetic changes are often not known or defined. In fact, such "fry and try" strategies may be viewed in considerably less favour if in the course of genome sequencing projects, any remnants of undesirable genes (toxins, virulence factors) are uncovered in generally regarded as safe (GRAS) lactic acid bacteria. Nevertheless, probiotics are well positioned in the "natural" and "functional" food categories. Any industries aligned with manufacturing of natural and organic products would be expected to adamantly exclude GMOs and favour traditional probiotics as a more natural approach.
Possible Developments
Genetic work on probiotic lactobacilli and bifidobacteria is in its infancy but promises to be a rapidly moving field that will reap rich benefits as knowledge accumulates and new discoveries support practical applications. At this juncture, some of the more critical research areas are as follows:
• Phenotype/genotype correlation of microbial characteristics that impact on probiotic functionality • Genome sequencing of lactobacilli and bifidobacteria • Molecular tools and gene transfer systems to support genetic modification and self cloning • Genetic modification to enhance existing characteristics and develop novel properties • Molecular signatures and tags • Investigate gene transfer and dissemination
Phenotype/Genotype Correlation of Microbial Characteristics that Impact Probiotic Functionality
Evidence supporting the in vivo roles of probiotics is needed to support the development of this industry. As such, demonstration of critical properties, genetic controls, and how they impact on in vivo functionality will be important. In this regard, the availability of the genome sequences of model probiotic species will facilitate correlation of genotypes with the capabilities and behaviour of probiotic strains. The genome project on Lactobacillus acidophilus will be completed by 2000 and is expected to fuel important efforts to understand the capabilities of lactobacilli in the gastrointestinal tract. Similarly, a genome project on Bifidobacterium should be initiated, with a model human species being a member of the B. longum/B. infantis group.
Molecular Tools and Gene Transfer Systems to Support Self Cloning
These techniques will be needed to support genetic analysis and modification of probiotic cultures. Efforts should be intensified to construct cloning, expression, and integration vectors that are of general utility in probiotic species. In conjunction, the availability of plasmid replicons, genetic markers, promoters, and terminators that are "self", originating from the targeted probiotic species, need to be developed concurrently. It is emphasized that efficient gene delivery systems (transformation, conjugation, transduction) are vital in the conduct of any genetic analysis Genetic Modification of Intestinal Bacteria 47 or modification of probiotic strains. The general utility and efficiency of these systems is still far below that needed to carry out genetic studies with many probiotic cultures.
Opportunities to Enhance Existing Characteristics and Develop Novel Properties by Genetic Modification of Probiotic Cultures
Potential targets for genetic modification and improvement include: immunostimulation and oral vaccine development; antimicrobials and bacteriocins; vitamin synthesis and production; adhesins and colonisation determinants; production and delivery of digestive enzymes; and metabolic engineering to alter products (e.g. polysaccharides; organic acids) or link cultures with specialty prebiotics designed to enhance the performance of a probiotic in vivo. In this regard, one attractive genetic target is to create molecular signatures or tags on the genomes of probiotic cultures. Modifications in the DNA sequence of an individual probiotic strain can be designed to allow rapid detection by specialised probes, PCR primers, or fingerprinting patterns. Molecular tags will not only allow definitive identification of novel probiotic strains, but further allow tracking their survival and dissemination through the environment or host organism. In this regard, use of new molecular methods to assess changes in the residing microbial communities (63, 78) , upon delivery of probiotics, will be another important research area.
Lastly, it will be vitally important to begin work on gene transfer and dissemination, in vivo. Probiotic cultures are often delivered in high daily doses into the oral and intestinal cavities. Little information is currently available on gene transfer from, or to, probiotic cultures, in vivo. Investigation of the genetic routes and transfer mechanisms available for probiotics in the gastrointestinal tract, as well as the capacity for probiotics to disseminate genes, will be an important area for future research. These studies will be a vital component in the portfolio of work needed to assess the safety of genetically modified probiotics in the host and the environment.
Conclusions
Genetic manipulation of intestinal lactobacilli and bifidobacteria presents the opportunity to investigate, determine, add and improve the traits considered important for their functional roles as probiotics. The potential to present bacteria, proteins, enzymes, and antigenic epitopes in selected intestinal locations via a bacterial delivery and expression system is quickly becoming a reality. Equally important may be genetic modifications that improve their in vivo effects or allow molecular tracking of fed probiotic strains in the human gastrointestinal tract. While substantial progress has been made in this exciting field over the past decade, there remain many barriers to be overcome in defining gene transfer, expression, and control, in lactobacilli and bifidobacteria of gastrointestinal origin.
